Matching‐adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed‐duration venetoclax and ibrutinib in patients with treatment‐naïve chronic lymphocytic leukaemia Article Swipe
Talha Munir
,
Leyla Mohseninejad
,
P. Rakonczai
,
Balázs Dobi
,
Sheng Xu
,
Keri Yang
,
Remus Vezan
,
Nicolás Martinez Calle
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1111/bjh.70241
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1111/bjh.70241
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1111/bjh.70241
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241
- OA Status
- hybrid
- References
- 6
- OpenAlex ID
- https://openalex.org/W4416101573
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416101573Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/bjh.70241Digital Object Identifier
- Title
-
Matching‐adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed‐duration venetoclax and ibrutinib in patients with treatment‐naïve chronic lymphocytic leukaemiaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-11Full publication date if available
- Authors
-
Talha Munir, Leyla Mohseninejad, P. Rakonczai, Balázs Dobi, Sheng Xu, Keri Yang, Remus Vezan, Nicolás Martinez CalleList of authors in order
- Landing page
-
https://doi.org/10.1111/bjh.70241Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
6Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416101573 |
|---|---|
| doi | https://doi.org/10.1111/bjh.70241 |
| ids.doi | https://doi.org/10.1111/bjh.70241 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41215737 |
| ids.openalex | https://openalex.org/W4416101573 |
| fwci | 0.0 |
| type | article |
| title | Matching‐adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed‐duration venetoclax and ibrutinib in patients with treatment‐naïve chronic lymphocytic leukaemia |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list.value | 4940 |
| apc_list.currency | USD |
| apc_list.value_usd | 4940 |
| apc_paid.value | 4940 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4940 |
| language | en |
| locations[0].id | doi:10.1111/bjh.70241 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S153015021 |
| locations[0].source.issn | 0007-1048, 1365-2141 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0007-1048 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | British Journal of Haematology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | British Journal of Haematology |
| locations[0].landing_page_url | https://doi.org/10.1111/bjh.70241 |
| locations[1].id | pmid:41215737 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | British journal of haematology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41215737 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5041332488 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2901-0769 |
| authorships[0].author.display_name | Talha Munir |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2799390153, https://openalex.org/I2801331674 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Clinical Haematology, Leeds Teaching Hospitals NHS Trust, Level 3, Bexley Wing, St James's University Hospital, Leeds, UK |
| authorships[0].institutions[0].id | https://openalex.org/I2799390153 |
| authorships[0].institutions[0].ror | https://ror.org/00v4dac24 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2799390153 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | Leeds Teaching Hospitals NHS Trust |
| authorships[0].institutions[1].id | https://openalex.org/I2801331674 |
| authorships[0].institutions[1].ror | https://ror.org/013s89d74 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I2799390153, https://openalex.org/I2801331674 |
| authorships[0].institutions[1].country_code | GB |
| authorships[0].institutions[1].display_name | St James's University Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Talha Munir |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Clinical Haematology, Leeds Teaching Hospitals NHS Trust, Level 3, Bexley Wing, St James's University Hospital, Leeds, UK |
| authorships[1].author.id | https://openalex.org/A5060405586 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Leyla Mohseninejad |
| authorships[1].affiliations[0].raw_affiliation_string | Integrative Evidence Generation and Health Economics, BeOne Medicines Netherlands BV, Schiphol, The Netherlands |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Leyla Mohseninejad |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Integrative Evidence Generation and Health Economics, BeOne Medicines Netherlands BV, Schiphol, The Netherlands |
| authorships[2].author.id | https://openalex.org/A5016695775 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | P. Rakonczai |
| authorships[2].affiliations[0].raw_affiliation_string | Health Economics and Market Access, Evidera by PPD, Budapest, Hungary |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Pal Rakonczai |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Health Economics and Market Access, Evidera by PPD, Budapest, Hungary |
| authorships[3].author.id | https://openalex.org/A5053599584 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1187-4104 |
| authorships[3].author.display_name | Balázs Dobi |
| authorships[3].affiliations[0].raw_affiliation_string | Health Economics and Market Access, Evidera by PPD, Budapest, Hungary |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Balazs Dobi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Health Economics and Market Access, Evidera by PPD, Budapest, Hungary |
| authorships[4].author.id | https://openalex.org/A5005788616 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0757-8289 |
| authorships[4].author.display_name | Sheng Xu |
| authorships[4].affiliations[0].raw_affiliation_string | Global Statistics and Data Science, BeOne Medicines (Shanghai) Co, Ltd, Shanghai, China |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sheng Xu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Global Statistics and Data Science, BeOne Medicines (Shanghai) Co, Ltd, Shanghai, China |
| authorships[5].author.id | https://openalex.org/A5024469663 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Keri Yang |
| authorships[5].affiliations[0].raw_affiliation_string | Integrative Evidence Generation and Health Economics, BeOne Medicines USA, Inc., Cambridge, Massachusetts, USA |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Keri Yang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Integrative Evidence Generation and Health Economics, BeOne Medicines USA, Inc., Cambridge, Massachusetts, USA |
| authorships[6].author.id | https://openalex.org/A5021322016 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Remus Vezan |
| authorships[6].affiliations[0].raw_affiliation_string | Clinical Development, Hematology, BeOne Medicines USA, Inc., Cambridge, Massachusetts, USA |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Remus Vezan |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Clinical Development, Hematology, BeOne Medicines USA, Inc., Cambridge, Massachusetts, USA |
| authorships[7].author.id | https://openalex.org/A5007915994 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Nicolás Martinez Calle |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1334287468 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK |
| authorships[7].institutions[0].id | https://openalex.org/I1334287468 |
| authorships[7].institutions[0].ror | https://ror.org/05y3qh794 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I1334287468 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | Nottingham University Hospitals NHS Trust |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Nicolás Martinez Calle |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-11T00:00:00 |
| display_name | Matching‐adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed‐duration venetoclax and ibrutinib in patients with treatment‐naïve chronic lymphocytic leukaemia |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T08:54:38.095128 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1111/bjh.70241 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S153015021 |
| best_oa_location.source.issn | 0007-1048, 1365-2141 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0007-1048 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | British Journal of Haematology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | British Journal of Haematology |
| best_oa_location.landing_page_url | https://doi.org/10.1111/bjh.70241 |
| primary_location.id | doi:10.1111/bjh.70241 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S153015021 |
| primary_location.source.issn | 0007-1048, 1365-2141 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0007-1048 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | British Journal of Haematology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70241 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | British Journal of Haematology |
| primary_location.landing_page_url | https://doi.org/10.1111/bjh.70241 |
| publication_date | 2025-11-11 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W1967008538, https://openalex.org/W3004696126, https://openalex.org/W4400269216, https://openalex.org/W4280503361, https://openalex.org/W4213453359, https://openalex.org/W2092901728 |
| referenced_works_count | 6 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5041332488 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| corresponding_institution_ids | https://openalex.org/I2799390153, https://openalex.org/I2801331674 |
| citation_normalized_percentile |